News Digest / Ticker: CRSP

Ticker: CRSP

08:50am, Tuesday, Jun 04, 2024

Cathie Wood Bets Big: Are CRISPR and Intellia Therapeutics Worth the Risk for Your Portfolio?

Cathie Wood's ARK Innovation ETF is eyeing biotech stocks CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA). CRISPR's stock is down 13% this year, with a promising gene-therapy product yet to deliver revenue. Intellia, down 27%, targets rare diseases but faces financial ...